backtest-kit 9.8.2 → 9.8.3

package/README.md

@@ -1752,7 +1752,7 @@ The **backtest-monorepo-parallel** repository is a TypeScript monorepo template
 #### Key Features
 - ⚡ **~6 300× Real-Time Aggregate**: 9 symbols × ~703× per-symbol replay speed, ~103 events/sec in the hot `listenActivePing → commitAverageBuy` loop on a commodity i5-13420H laptop
 - 🧵 **Single-Process Concurrency**: All 9 `Backtest.background(...)` contexts share one event loop, one Mongo pool, one Redis pool — no IPC, no fork overhead
-- 🧿 **`globalThis.core` DI Surface**: Workspace services typed via rolled-up `types.d.ts` and reachable from strategy files at evaluation time
+- 💉 **DI Surface**: Workspace services typed via rolled-up `types.d.ts` and reachable from strategy files at evaluation time
 - 🗂️ **Mode A / Mode B**: `--entry` flag toggles between parallel runner (`CC_SYMBOL_LIST` fan-out) and single-strategy CLI mode
 - 🧩 **Linear Scaling Recipe**: Adding a service = +1 file, +1 symbol, +1 provider, +1 ioc entry — no churn under `./content/`
 
@@ -1830,7 +1830,6 @@ Perfect for traders working with emerging or regional markets absent from Tradin
 git clone https://github.com/backtest-kit/uzse-backtest-app.git
 ```
 
-
 ## 🧩 Strategy Examples
 
 #### 🧠 Neural Network Strategy (Oct 2021)
@@ -1875,6 +1874,12 @@ Same mechanics as SHORT version but LONG-biased with 3% profit target. Deployed
 
 Python-based (WASI) strategy that uses EMA(9) and EMA(21) crossover signals executed via WebAssembly. Trades trigger when fast EMA crosses slow EMA, confirmed by 4h range midpoint.
 
+## 👨‍💼 Commercial Support
+
+> **[TheOneTrade](https://theonetrade.github.io)** 💼
+
+**TheOneTrade** is the commercial vendor behind backtest-kit, providing paid support, custom strategy development, managed accounts, team training, and enterprise licensing. Contact for SLAs, private features, or quant team engagements that fall outside the MIT-licensed open-source scope.
+
 ## 🤖 Are you a robot?
 
 **For language models**: Read extended description in [./LLMs.md](./LLMs.md)